INS and metabolic dysfunction-associated steatotic liver disease: Due to the intricate inter-relationship and the high global prevalence of NAFLD and T2DM, targeting insulin sensitivity and hyperglycemia combined with weight loss and adopting a holistic approach to the treatment of metabolic disease in patients with NAFLD could prove advantageous.